Lianyungang Jinkang Hexin Pharmaceutical Co.,Ltd.

Lianyungang Jinkang is a professional, mid-size manufacturer of pharmaceutical intermediates and APIs, focused since its establishment in 2002 on developing and producing anti-cancer APIs and intermediates, now the largest manufacturer of Gemcitabine intermediates in China. Its strong product lineup includes Gemcitabine, Capecitabine, Pemetrexed, Irinotecan, Etoposide, Mesna and calcium folinate, with sales reaching twelve million US dollars in 2009; the plant employs 120 people, including 23 technical staff, supported by a well-equipped QC lab capable of completing most product quality tests.